CD33-D2 isoform characterization for advancement of its therapeutic potential
The results establish the relevance of targeting IgC domain as an alternative immunotarget to supplement AML chemotherapy.
Authors
- Jatinder K. Lamba (ORCID: https://orcid.org/0000-0003-0411-0007)
- Vivek M. Shastri (ORCID: https://orcid.org/0009-0003-1105-1575)
- Srideshikan Sargur Madabushi (ORCID: https://orcid.org/0000-0002-1087-6044)
- Susanta Hui (ORCID: https://orcid.org/0000-0002-1394-3724)
Institutions
- City Of Hope National Medical Center (US)
- University of Florida (US)
Publication Details
- Journal
- Immunotherapy
- Published
- 2025-03-24
- DOI
- https://doi.org/10.1080/1750743x.2025.2493038
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Cancer Institute